Form 8-K - Current report:
SEC Accession No. 0001213900-25-072062
Filing Date
2025-08-05
Accepted
2025-08-05 16:01:39
Documents
14
Period of Report
2025-08-04
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0251774-8k_silo.htm   iXBRL 8-K 24517
2 PRESS RELEASE DATED AUGUST 5, 2025 ea025177402ex99-1_silo.htm EX-99.1 8113
3 GRAPHIC ex99-1_001.jpg GRAPHIC 8882
  Complete submission text file 0001213900-25-072062.txt   212528

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE silo-20250804.xsd EX-101.SCH 3020
5 XBRL LABEL FILE silo-20250804_lab.xml EX-101.LAB 34239
6 XBRL PRESENTATION FILE silo-20250804_pre.xml EX-101.PRE 22362
16 EXTRACTED XBRL INSTANCE DOCUMENT ea0251774-8k_silo_htm.xml XML 3566
Mailing Address 677 N. WASHINGTON BLVD SARASOTA FL 34236
Business Address 677 N. WASHINGTON BLVD SARASOTA FL 34236 (718) 400-9031
Silo Pharma, Inc. (Filer) CIK: 0001514183 (see all company filings)

EIN.: 462137136 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41512 | Film No.: 251184749
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)